Filing Flows › Bioventus (BVS) › Net income
Bioventus (BVS) net income by quarter
Bioventus' net income was $6.0M in Q3 2026 (third quarter 2026), -82% from Q2 2026. Over the last 6 quarters it ranged from $3.1M (Q1 2026) to $33.4M (Q2 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $6.0M | -82% | +90% |
| Q2 2026 | $33.4M | +974% | +348% |
| Q1 2026 | $3.1M | -79% | — |
| Q4 2025 | $14.8M | +368% | — |
| Q3 2025 | $3.2M | -58% | — |
| Q2 2025 | $7.5M | — | — |
Q3 2026 at a glance
Bioventus, Q3 2026: revenue $142M (+3% year over year), operating margin 6.8%, net earnings $6.0M, operating cash flow $20.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bioventus' net income?
Bioventus' net income was $6.0M in Q3 2026 (third quarter 2026), -82% from Q2 2026.
How has Bioventus' net income changed?
Over the last 6 quarters it ranged from $3.1M (Q1 2026) to $33.4M (Q2 2026).